(临床医学)DIC弥散性血管内凝血课件.ppt
- 【下载声明】
1. 本站全部试题类文档,若标题没写含答案,则无答案;标题注明含答案的文档,主观题也可能无答案。请谨慎下单,一旦售出,不予退换。
2. 本站全部PPT文档均不含视频和音频,PPT中出现的音频或视频标识(或文字)仅表示流程,实际无音频或视频文件。请谨慎下单,一旦售出,不予退换。
3. 本页资料《(临床医学)DIC弥散性血管内凝血课件.ppt》由用户(晟晟文业)主动上传,其收益全归该用户。163文库仅提供信息存储空间,仅对该用户上传内容的表现方式做保护处理,对上传内容本身不做任何修改或编辑。 若此文所含内容侵犯了您的版权或隐私,请立即通知163文库(点击联系客服),我们立即给予删除!
4. 请根据预览情况,自愿下载本文。本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
5. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007及以上版本和PDF阅读器,压缩文件请下载最新的WinRAR软件解压。
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- 临床医学 DIC 弥散 血管 凝血 课件
- 资源描述:
-
1、1Disseminated intravascular coagulation2 Intravascular Extravascular Normal circulation Hemostasis liquidity solidity (coagulation)Normal Normal Blood Abnomal Abnomal solidity (coagulation)liqidity Thrombotic disease Hemorrhagic disease Intravascular Extravascular3 The function of coagulation system
2、 (Extrinsic,Intrinsic pathway and platelet)The function of anticoagulation (TFPI,PC system,ATIII and fibrinolytic system)The regulation of balance by VECThe key factors for balance of coagulation-anticoagulation:4The chain reaction of blood coagulation FXI FXIa FVII/FVIIa-TF-Ca2+(on membrane)FIX FIX
3、a TFPI-FXa FVIIIa Ca2+-PL prothrombin(FII)PCI FX Fxa PL-Ca2+Fva APC (PS)XIII thrombin TM-on-VEC XIIIa ATIII PC Fbn Fbn FM Fbg(FI)(cross-linked)(soluble)TF=tissue factor;TFPI=TF pathway inhibitor;Fbg=fibrinogen;Fbn=fibrin;FM=fibrin monomer;PC=protein C;APC=activated PC;PS=protein S;PCI=PC inhibitor A
4、TIII=antithrombin III;TM=thrombomodulin;VEC=vascular EC5The fibrinolysis system Plasminogen(PLg)(Extra-activating pathway)(Intra-activating pathway)tissue-type plasminogen activation of clotting system activator(t-PA)XIa urokinase-type plasminogen thrombin activator(u-PA)XIIa XII(Exogenous activator
5、)urokinase(UK)kallikrein(KK)streptokinase(SK)prekallikrein(PK)Plasmin(Pln)Fbg Fbn FDP (fibrinogen)(fibrin)(Fbg/Fbn degradation products)6Inhibit Xa,VIIa,TFInhibit platelet aggregationFibrinolysisPrevent fibrinclot formationTraumaAdrenalinThrombinADPNO,PGI2 Xa,IIaPlasminPlasminoginActivatorst-PA,u-PA
6、InactivateVa,VIIIaPSThrombinPC APCTMInhibit Xa,IIaAT III+HeparinTFPIAnticoagulant function of endothelial cells7Section 1.Concept and causes of DIC 8Todays Question Question 1.What is DIC?91.Concept of DIC Disseminated intravascular coagulation(DIC)A syndrome that results from the disturbance of kin
7、etic balance of coagulation and fibrinolytic processes.Characterized by extensive intravascular microthrombosis and impairment of hemostasia.Its initial link is activation of clotting system in the body 10extensive microthrombin extensive hemorrhage organ dysfunction Shock aneamiaNormal balance of c
8、oagulation-anticoagulationHypocoagulable stateHypercoagulable stateUnbalance of coagulation-anticoagulation and DICextensive activation of clotting factors and platelets consumption of clotting factors and plateletssecondary fibrinolysishemorrhageorgan dysfunction Shock aneamia11 Therefore DIC usual
9、ly associated simultaneously with both hemorrhage and thrombosis.Its clinical presentations include:1)extensive hemorrhage at skin,mucosa and internal organs (viscera);2)shock;3)organ dysfunction;4)aneamia.An extensive activation of coagulation process caused by the entering of coagulation-promoting
10、 substances into circulationAn increased consumption of clotting factors and platelets,deposition of fibrin and secondary fibrinolysis.results in122.Causes of DIC including:infectious diseases,extensive tissue injury,obstetric complications,malignant tumors,acute leukemia,shock,hepatic and renal dis
11、eases,collagen disease,metabolic diseases,cardiovascular diseases,intravascular hemolysisEtiologic Disease of DIC Diseases or pathologic process which may lead to DICTriggering Factor Any factors which may trigger or promote DIC occur13 including:infectious diseases,extensive tissue injury,obstetric
12、 complications,malignant tumors,acute leukemia,shock,hepatic and renal diseases,collagen disease,metabolic diseases,cardiovascular diseases,intravascular hemolysis2.Causes of DICTriggering Factor Any factors which may trigger or promote DIC occurEtiologic Disease of DIC Diseases or pathologic proces
13、s which may lead to DIC1)Tissue injury and release tissue factor(TF)2)Vascular endothelial cells(VEC)injury3)bacterial endotoxin4)Ag-Ab complex5)Protein hydrolytic enzymes6)Particle or colloid7)Virus and other microbe14Section 2.Pathogenesis of DIC15 The mechanism of DIC is very complex and remains
14、unclear up to now.The common pathogenic process include:1)Triggering clotting activation,producing numerous insoluble fibrin(Fbn)and activating platelets;2)The generated Fbn deposit in microvessels and is more than hydrolytic ability of fibrinolysin;3)Alteration of fibrinolysis function during the D
15、IC process which is related to the pathologic process of micro-thrombosis and bleeding tendency.161.Activation of clotting system As soon as activation,the clotting response will be magnified by cascade or limited by negative feedback.The clotting system is liable to be activated in the microvessels
16、,leading to micro-thrombus formation.The causes and pathogenesis of clotting system activation including:(1)Tissue injury (2)Vascular endothelial cells injury (3)Other pathway to activate clotting system17(1)Tissue injurySevere trauma,burns,surgical operation,obstetric accident,tumor tissue necrosis
17、 or metastasis,blood cell injury(radiation or chemical therapy for leukemia)Excessive destruction of tissue Numerous TF entering the blood Activating clotting reactions Besides,lysozymes released by lysosome of damaged cells may also promote the activation of clotting system.18Infectious,endotoxinem
18、ia,Ag-Ab complex,persistent ischemia and hypoxia,acidosis extensive damage of vascular endothelial cells .activating clotting reactions (activating Mo/Mf,PMN,T-lymphocyte release TNF,IL-1,IFN,PAF,C3a,C5a,O2)(2)Vascular endothelial cells injuryreleasing TF subendothelial exposureplatelets adhesion Ag
19、gregation and release19 Activation of Mo/Mf,WBC release TF,lysozymes Malignant tumors release TF,cancer procoagulant Hemorrhagic pancreatitis,cancer of pancreas release trypsin(may activate prothrombin directly)Exogenous toxin activate FX,prothrombin or transfer Fbg to Fbn directly Extensive hemolys
20、is release ADP activate platelets release erythrin TF-like effect(3)Other pathway to activate clotting system202.Change of vasomotorial activity and blood fluidity VEC injury EDRF,PGI2,ETPlatelet activated TXA2Blood flow(vasoconstriction)or stasis(vasodilation)eliminate of coagulant or activate clot
21、ting factors PAF,histamin,BK vascular permeability (BK:bradykinin)Deposit of FbnBlood condense,Viscosity213.Disturbance of fibrinolysis (1)Local fibrinolysis clotting VEC injury local anticoagultive and fibrinolytic function deposit of Fbn microthrombus formation (2)Secondary fibrinolysis bleeding F
22、XIa,thrombin,KK,etc.promote transfer PLg to PLn VEC release t-PA,u-PA transfer PLg to PLn Protein C activated by thrombin(via VEC-TM)form activated protein C(APC)anticoagulation and promote fibrinolysis.22 Pathological Factors extensive activation of clotting factors and platelets intravascular coag
23、ulation consumption of clotting secondary factors and platelets fibrinolysis extensive hemorrhage aneamia shock organ dysfunction (Disseminated intravascular coagulation,DIC)Hypercoagulable stateHypocoagulable state23Section 3.Primary clinical presentations of DIC24DIC may lead to four consequences
24、as follows:1.Disturbance of coagulation -Bleeding 2.Disturbance of microcirculation-Shock 3.multiple organs dysfunction-MOD 4.Microangiopathic hemolytic-Anemia251.Disturbance of coagulation-BleedingThe prime and common symptom of DIC is bleeding.The features of bleeding in DIC:(1)High occurrence rat
25、e(7080%)(2)Difficult to explain by primary disease (3)Manifold bleeding types (4)Difficult to be cured by regular hemostatics26The causes of bleeding in DIC including:(1)Excessive consumption of coagulation substances (clotting factors and platelets);(2)Secondary enhance of fibrinolysis (3)Anticoagu
展开阅读全文